102 related articles for article (PubMed ID: 14694444)
1. Antisense blocking of BRCA1 enhances sensitivity to plumbagin but not tamoxifen in BG-1 ovarian cancer cells.
Srinivas G; Annab LA; Gopinath G; Banerji A; Srinivas P
Mol Carcinog; 2004 Jan; 39(1):15-25. PubMed ID: 14694444
[TBL] [Abstract][Full Text] [Related]
2. Structure activity relationship of plumbagin in BRCA1 related cancer cells.
K A T; T R; G R; K C S; Nair RS; G S; Banerji A; Somasundaram V; Srinivas P
Mol Carcinog; 2013 May; 52(5):392-403. PubMed ID: 22290577
[TBL] [Abstract][Full Text] [Related]
3. Estrogen-dependent cell signaling and apoptosis in BRCA1-blocked BG1 ovarian cancer cells in response to plumbagin and other chemotherapeutic agents.
Thasni KA; Rakesh S; Rojini G; Ratheeshkumar T; Srinivas G; Priya S
Ann Oncol; 2008 Apr; 19(4):696-705. PubMed ID: 18187487
[TBL] [Abstract][Full Text] [Related]
4. Plumbagin induces reactive oxygen species, which mediate apoptosis in human cervical cancer cells.
Srinivas P; Gopinath G; Banerji A; Dinakar A; Srinivas G
Mol Carcinog; 2004 Aug; 40(4):201-11. PubMed ID: 15264212
[TBL] [Abstract][Full Text] [Related]
5. Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) induces apoptosis and cell cycle arrest in A549 cells through p53 accumulation via c-Jun NH2-terminal kinase-mediated phosphorylation at serine 15 in vitro and in vivo.
Hsu YL; Cho CY; Kuo PL; Huang YT; Lin CC
J Pharmacol Exp Ther; 2006 Aug; 318(2):484-94. PubMed ID: 16632641
[TBL] [Abstract][Full Text] [Related]
6. Increased cell survival by inhibition of BRCA1 using an antisense approach in an estrogen responsive ovarian carcinoma cell line.
Annab LA; Hawkins RE; Solomon G; Barrett JC; Afshari CA
Breast Cancer Res; 2000; 2(2):139-48. PubMed ID: 11056686
[TBL] [Abstract][Full Text] [Related]
7. Rationale for sequential tamoxifen and anticancer drugs in adjuvant setting for patients with node- and receptor-positive breast cancer.
Kim R; Tanabe K; Emi M; Uchida Y; Osaki A; Toge T
Int J Oncol; 2005 Apr; 26(4):1025-31. PubMed ID: 15753998
[TBL] [Abstract][Full Text] [Related]
8. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
9. Emodin sensitizes paclitaxel-resistant human ovarian cancer cells to paclitaxel-induced apoptosis in vitro.
Li J; Liu P; Mao H; Wanga A; Zhang X
Oncol Rep; 2009 Jun; 21(6):1605-10. PubMed ID: 19424643
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of tamoxifen in estrogen receptor-positive breast cancer cells is enhanced by a medical nutriment.
Marcsek Z; Kocsis Z; Jakab M; Szende B; Tompa A
Cancer Biother Radiopharm; 2004 Dec; 19(6):746-53. PubMed ID: 15665622
[TBL] [Abstract][Full Text] [Related]
11. Plumbagin-induced apoptosis of human breast cancer cells is mediated by inactivation of NF-kappaB and Bcl-2.
Ahmad A; Banerjee S; Wang Z; Kong D; Sarkar FH
J Cell Biochem; 2008 Dec; 105(6):1461-71. PubMed ID: 18980240
[TBL] [Abstract][Full Text] [Related]
12. Plumbagin induces ROS-mediated apoptosis in human promyelocytic leukemia cells in vivo.
Xu KH; Lu DP
Leuk Res; 2010 May; 34(5):658-65. PubMed ID: 19748668
[TBL] [Abstract][Full Text] [Related]
13. [Study of effect of mifepristone on apoptosis of human ovarian cancer cell line 3AO].
Li Q; Li JJ; Zhao XB; Ji M
Zhonghua Fu Chan Ke Za Zhi; 2003 Oct; 38(10):625-8. PubMed ID: 14728868
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor-positive human epithelial ovarian carcinoma cells respond to the antitumor drug suramin with increased proliferation: possible insight into ER and epidermal growth factor signaling interactions in ovarian cancer.
Kalli KR; Bradley SV; Fuchshuber S; Conover CA
Gynecol Oncol; 2004 Sep; 94(3):705-12. PubMed ID: 15350362
[TBL] [Abstract][Full Text] [Related]
15. Suppression of human ovarian SKOV-3 cancer cell growth by Duchesnea phenolic fraction is associated with cell cycle arrest and apoptosis.
Peng B; Chang Q; Wang L; Hu Q; Wang Y; Tang J; Liu X
Gynecol Oncol; 2008 Jan; 108(1):173-81. PubMed ID: 17959232
[TBL] [Abstract][Full Text] [Related]
16. Emodin-induced apoptosis in human breast cancer BCap-37 cells through the mitochondrial signaling pathway.
Huang Z; Chen G; Shi P
Arch Pharm Res; 2008 Jun; 31(6):742-8. PubMed ID: 18563356
[TBL] [Abstract][Full Text] [Related]
17. Effect of combined treatment with progesterone and tamoxifen on the growth and apoptosis of human ovarian cancer cells.
Lee JY; Shin JY; Kim HS; Heo JI; Kho YJ; Kang HJ; Park SH; Lee JY
Oncol Rep; 2012 Jan; 27(1):87-93. PubMed ID: 21922150
[TBL] [Abstract][Full Text] [Related]
18. Dominant-negative activity of a Brca1 truncation mutant: effects on proliferation, tumorigenicity in vivo, and chemosensitivity in a mouse ovarian cancer cell line.
Sylvain V; Lafarge S; Bignon YJ
Int J Oncol; 2002 Apr; 20(4):845-53. PubMed ID: 11894135
[TBL] [Abstract][Full Text] [Related]
19. Mutant BRCA1 genes antagonize phenotype of wild-type BRCA1.
Fan S; Yuan R; Ma YX; Meng Q; Goldberg ID; Rosen EM
Oncogene; 2001 Dec; 20(57):8215-35. PubMed ID: 11781837
[TBL] [Abstract][Full Text] [Related]
20. Glucose-regulated protein 78 as a novel effector of BRCA1 for inhibiting stress-induced apoptosis.
Yeung BH; Kwan BW; He QY; Lee AS; Liu J; Wong AS
Oncogene; 2008 Dec; 27(53):6782-9. PubMed ID: 18776923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
